​
​

Akanda Stock (NASDAQ:AKAN)

RevenueOwnershipFinancialsChart
Akanda by TradingView

Previous Close

$1.40

52W Range

$1.22 - $56.80

50D Avg

$1.96

200D Avg

$7.24

Market Cap

$1.95M

Avg Vol (3M)

$359.54K

Beta

1.52

Div Yield

-

AKAN Company Profile

Akanda Corp., through its subsidiaries, engages in the cultivation, manufacture, and distribution of cannabis products in the United Kingdom, Lesotho, and internationally. It intends to supply cannabis based medical and wellness products. The company was incorporated in 2021 and is headquartered in New Romney, the United Kingdom.

Show More

Industry

Drug Manufacturers - Specialty & Generic

Sector

Healthcare

Exchange

NASDAQ

ADR

-

Country

GB

Employees

46

IPO Date

Mar 15, 2022

Website

AKAN Performance

AKAN Financial Summary

Dec 23Dec 22Dec 21
Revenue$2.16M$2.62M$41.43K
Operating Income$-9.91M$-20.18M$-6.83M
Net Income$-32.28M$397.05K$-9.22M
EBITDA$-5.63M$-16.41M$-6.50M
Basic EPS$-7.16$0.11$-3.19
Diluted EPS$-7.16$0.11$-3.19

Fiscal year ends in Dec 23 | Currency in USD

Peer Comparison

TickerCompany
SNOASonoma Pharmaceuticals, Inc.
BFRIBiofrontera Inc.
ACORAcorda Therapeutics, Inc.
LFCRLifecore Biomedical, Inc.
UPCUniverse Pharmaceuticals INC
GHSIGuardion Health Sciences, Inc.
SHPHShuttle Pharmaceuticals Holdings, Inc.
DERMJourney Medical Corporation
PTPIPetros Pharmaceuticals, Inc.
LSDILucy Scientific Discovery Inc.
SXTCChina SXT Pharmaceuticals, Inc.